Literature DB >> 2826360

Characterization of the conjunctival vasopermeability response to leukotrienes and their involvement in immediate hypersensitivity.

R K Gary1, D F Woodward, A L Nieves, L S Williams, J G Gleason, M A Wasserman.   

Abstract

The microvascular permeability response of the guinea pig conjunctiva to sulfidopeptide leukotrienes (LTs) was quantified as extravasation of radiolabeled bovine serum albumin. The LTs were potent inducers of increased microvascular permeability, with relative potencies LTE4 greater than or equal to LTD4 greater than LTC4. The response to LTs was unaffected by indomethacin or a pyrilamine/cimetidine combination, but the LT antagonists FPL 55712 and SKF 102922 significantly inhibited the response to LTC4, LTD4 and LTE4. In guinea pigs actively sensitized to ovalbumin, topical ocular administration of ovalbumin markedly increased conjunctival microvascular permeability; this response was reduced by approximately 50% following histaminergic blockade by pyrilamine/cimetidine. FPL 55712 and SKF 102922 and the 5-lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA) had no effect on the response to antigen when used alone. However, each agent significantly reduced the non-histaminergic component of the response when given in conjunction with pyrilamine/cimetidine. Thus, it appears that the immediate hypersensitivity response in guinea pig conjunctiva has a possible non-histaminergic component which is at least partly mediated by LTs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826360

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.

Authors:  C S Spada; D F Woodward; S B Hawley; A L Nieves; L S Williams; B J Feldmann
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

2.  Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model.

Authors:  A Leonardi; F Busato; I Fregona; M Plebani; A G Secchi
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

3.  A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye.

Authors:  Alla Musiyenko; Lucia Correa; Nicholas Stock; John H Hutchinson; Daniel S Lorrain; Gretchen Bain; Jilly F Evans; Sailen Barik
Journal:  Clin Vaccine Immunol       Date:  2009-09-16

4.  Platelet-activating factor: an inflammatory mediator in the acute phase of allergic conjunctivitis in a guinea-pig model.

Authors:  F Meijer; J L Delft; N J Haeringen
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.